Skip to content

Application of IVA in improving ovarian tissue utilization

Application of IVA in improving ovarian tissue utilization

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036961
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian dysfunction and premature ovarian failure

Interventions

Induced fetus group :Cryopreservation, IVA activation
Women or girls with malignant tumors:Cryopreservation, partial resuscitation, IVA activation
Women with premature ovarian failure:Cryopreservation, partial resuscitation, IVA activation

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
8 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. Women fetal with normal ovarian tissue and induced labor for various reasons. 2. Adult women or girls with malignant tumor who are willing to preserve fertility. 3. Women with premature ovarian failure who have fertility requirements have no other disease complications. 4. Agree with the informed content of this study.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data; 2. Women with premature ovarian failure complicated with tumor, infection and other diseases not suitable for pregnancy.

Design outcomes

Primary

MeasureTime frame
Follicular typing and counting, follicular development;Follicular typing and counting, follicular development;

Countries

China

Contacts

Public ContactXiaowei LU

Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University

luxiaowei@xinhuamed.com.cn+86 13818281160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026